Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2-3 Study of Efficacy and Safety of Reduced Pelvic Floor Mesh Implants

NCT01739374 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT01739374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2-3 Study of Efficacy and Safety of Reduced Pelvic Floor Mesh Implants
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2013
Completion date
March 31, 2015
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

complication of surgical procedure, post operative pain